2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension. (Q45746313)
Jump to navigation
Jump to search
scientific article published on 15 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension. |
scientific article published on 15 September 2008 |
Statements
1 reference
2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension (English)
N Ruperto
DJ Lovell
R Cuttica
P Woo
G Espada
ED Silverman
Z Balogh
M Henrickson
J Davidson
I Foeldvari
L Imundo
G Simonini
J Oppermann
YK Shen
S Visvanathan
A Fasanmade
A Mendelsohn
A Martini
15 September 2008
1 reference
1 September 2008
1 reference